MOSPD2 is a therapeutic target for the treatment of CNS inflammation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MOSPD2 is a therapeutic target for the treatment of CNS inflammation
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-05-01
DOI
10.1111/cei.13448
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation
- (2019) Marta Joana Costa Jordão et al. SCIENCE
- The fate and lifespan of human monocyte subsets in steady state and systemic inflammation
- (2017) Amit A. Patel et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Autonomous TNF is critical for in vivo monocyte survival in steady state and inflammation
- (2017) Yochai Wolf et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Identification of Motile Sperm Domain–Containing Protein 2 as Regulator of Human Monocyte Migration
- (2017) Itzhak Mendel et al. JOURNAL OF IMMUNOLOGY
- Myeloid cell transmigration across the CNS vasculature triggers IL-1β–driven neuroinflammation during autoimmune encephalomyelitis in mice
- (2016) Sébastien A. Lévesque et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Myeloid cells — targets of medication in multiple sclerosis
- (2016) Manoj K. Mishra et al. Nature Reviews Neurology
- Specification of tissue-resident macrophages during organogenesis
- (2016) E. Mass et al. SCIENCE
- Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammation
- (2015) Agata A. Mossakowski et al. ACTA NEUROPATHOLOGICA
- Macrophages: Development and Tissue Specialization
- (2015) Chen Varol et al. Annual Review of Immunology
- Differential roles of microglia and monocytes in the inflamed central nervous system
- (2014) Ryo Yamasaki et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Chemokines and Chemokine Receptors in Multiple Sclerosis
- (2014) Wenjing Cheng et al. MEDIATORS OF INFLAMMATION
- Tissue-Resident Macrophages Self-Maintain Locally throughout Adult Life with Minimal Contribution from Circulating Monocytes
- (2013) Daigo Hashimoto et al. IMMUNITY
- Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
- (2011) Bahareh Ajami et al. NATURE NEUROSCIENCE
- Radical changes in multiple sclerosis pathogenesis
- (2010) Jack van Horssen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The blood–brain barrier, chemokines and multiple sclerosis
- (2010) David W. Holman et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease
- (2009) I. L. King et al. BLOOD
- CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system
- (2009) Alexander Mildner et al. BRAIN
- The use of chemokine antagonists in EAE models
- (2008) Amanda E.I. Proudfoot et al. JOURNAL OF NEUROIMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More